查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1585682

禽流感治疗市场：按类型、最终用户划分 - 2025-2030 年全球预测

Bird Flu Treatment Market by Type (Antivirals, Combination Treatment, Prophylactic Antibiotics), End-User (Clinics, Hospital, Institutional Health Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年禽流感治疗市场规模为220.6亿美元，预计2024年将达到238.5亿美元，复合年增长率为8.18%，预计到2030年将达到382.7亿美元。

禽流感治疗市场包括频谱旨在管理和潜在治癒禽流感的产品和服务，禽流感是一种对家禽业和公共卫生都有重大影响的病毒性疾病。这个市场的推动是为了控制禽流感的爆发，禽流感影响家禽业，并且可以跨物种传染给人类，因此需要提供预防性疫苗和抗病毒治疗。禽流感治疗的应用范围包括动物用药品、人类保健和农业环境中的生态系统管理。最终用户包括家禽养殖户、医疗保健提供者、政府以及参与粮食安全和疾病预防的组织。影响市场的主要成长要素包括由于迁徙模式导致禽流感爆发频率增加、消费者对通用感染疾病的认识不断提高以及疫苗和治疗方法开发的进步。该市场的机会在于增强的监测技术、增强的生物安全措施以及扩大频谱抗病毒药物的可用性。政府和组织可以透过投资更有效的疫苗研发以及建立公私伙伴关係来简化应对策略，从而利用这些机会。然而，挑战依然存在，包括疫苗开发相关的高成本、大规模免疫宣传活动的物流、监管障碍以及病毒快速变异导致疫苗抗药性的能力。由于新兴国家获得有效治疗方法的机会有限，市场情势进一步复杂化。创新可以集中在 mRNA 疫苗平台、人工智慧驱动的流行病预测模型和改进的抗病毒配方上。促进跨部门合作还可以促进预防和管理疫情的全面解决方案。市场动态是动态的，其特点是对创新解决方案的迫切需求和严格的监管要求。长期永续性取决于风险评估、敏捷应变计画以及对创新技术和全球合作的持续投资。

主要市场统计
基准年[2023] 220.6亿美元
预测年份 [2024] 238.5亿美元
预测年份 [2030] 382.7亿美元
复合年增长率（%） 8.18%

市场动态：快速发展的禽流感治疗市场的关键市场洞察

供需的动态交互作用正在改变禽流感治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 禽流感和其他通用感染疾病的盛行率增加
    • 提高大众对禽流感的认识
    • 政府不断采取措施开发更好的治疗方法
  • 市场限制因素
    • 病毒对现有抗病毒药物产生抗药性以及与药物开发相关的高成本
  • 市场机会
    • 新产品开发新投资
    • 禽流感治疗药物临床试验正在进行中
  • 市场挑战
    • 严格的法规和核准流程

波特五力：驾驭禽流感治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解禽流感治疗市场的外部影响

外部宏观环境因素对禽流感治疗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解禽流感治疗市场的竞争状况

对禽流感治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 禽流感治疗市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估禽流感治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘禽流感治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，禽流感治疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 禽流感和其他通用感染疾病的盛行率增加
      • 大众对禽流感的认识有所提高
      • 政府不断努力开发更好的治疗方法
    • 抑制因素
      • 病毒对现有抗病毒药物产生抗药性以及与药物开发相关的高成本
    • 机会
      • 新产品开发新投资
      • 治疗禽流感的临床试验正在进行中
    • 任务
      • 严格的法规和核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章禽流感治疗市场：依类型

  • 抗病毒药物
  • 合併治疗
  • 预防性抗生素
  • Ribavirin

第七章禽流感治疗市场：依最终使用者分类

  • 诊所
  • 医院
  • 设施健康中心

第八章北美和南美禽流感治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太禽流感治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲禽流感治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO SpA
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.
Product Code: MRR-CA17E905EAFA

The Bird Flu Treatment Market was valued at USD 22.06 billion in 2023, expected to reach USD 23.85 billion in 2024, and is projected to grow at a CAGR of 8.18%, to USD 38.27 billion by 2030.

The bird flu treatment market encompasses the spectrum of products and services aimed at managing and potentially curing avian influenza, a viral disease significantly impacting both poultry industries and public health. This market is driven by the necessity to control outbreaks that affect poultry farming and can cross species to humans, necessitating both preventive vaccines and antiviral therapeutics. Applications of bird flu treatments extend to veterinary pharmaceuticals, human healthcare, and ecosystem management within agricultural settings. End users include poultry farmers, healthcare providers, governments, and organizations involved in food security and disease prevention. Key growth factors influencing the market include the increasing frequency of bird flu outbreaks due to migratory patterns, rising consumer awareness about zoonotic diseases, and advancements in vaccine and therapeutic development. Opportunities within this market lie in enhancing surveillance technologies, strengthening biosecurity measures, and expanding the availability of broad-spectrum antivirals. Governments and organizations can capitalize on these opportunities by investing in R&D for more efficient vaccines and creating partnerships between the public and private sectors to streamline response strategies. However, challenges persist, including high costs associated with vaccine development, logistics of mass immunization campaigns, regulatory hurdles, and the virus's capacity for rapid mutation leading to vaccine resistance. Limited access to effective treatments in developing countries further complicates the market landscape. Innovations could focus on mRNA vaccine platforms, AI-driven outbreak prediction models, and improving antiviral formulations. Encouraging cross-sector collaboration could also facilitate comprehensive solutions to prevent and manage outbreaks. The market for bird flu treatment is dynamic, characterized by urgent demand for innovative solutions and stringent regulatory requirements. Long-term sustainability will depend on risk assessment, agile response planning, and continual investment in innovative technologies and cooperative global initiatives.

KEY MARKET STATISTICS
Base Year [2023] USD 22.06 billion
Estimated Year [2024] USD 23.85 billion
Forecast Year [2030] USD 38.27 billion
CAGR (%) 8.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bird Flu Treatment Market

The Bird Flu Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of avian influenza and other zoonotic diseases
    • Growing awareness of bird flu among population
    • Rising government initiatives to develop better therapeutics
  • Market Restraints
    • Resistance of the virus to existing antiviral drugs and high costs associated with therapeutics development
  • Market Opportunities
    • Emerging investment for novel product development
    • Ongoing clinical trials for bird flu treatments
  • Market Challenges
    • Stringent regulatory and approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Bird Flu Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bird Flu Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bird Flu Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bird Flu Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bird Flu Treatment Market

A detailed market share analysis in the Bird Flu Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bird Flu Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bird Flu Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bird Flu Treatment Market

A strategic analysis of the Bird Flu Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bird Flu Treatment Market, highlighting leading vendors and their innovative profiles. These include Alltech, Inc., BioCryst Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cipla Limited, CSL Limited, F. Hoffmann-La Roche Ltd., FATRO S.p.A., Gilead Sciences, Inc., GlaxoSmithKline PLC, Hester Biosciences Limited, Johnson & Johnson Services, Inc., Macleods Pharmaceuticals Ltd, Merck KGaA, Moderna, Inc., Novartis AG, PetSmart LLC, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Takeda Pharmaceutical Company Limited, Tianjin Ringpu Biotechnology Co. Ltd., Yebio Bioengineering Co. Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Bird Flu Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antivirals, Combination Treatment, Prophylactic Antibiotics, and Ribavirin.
  • Based on End-User, market is studied across Clinics, Hospital, and Institutional Health Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of avian influenza and other zoonotic diseases
      • 5.1.1.2. Growing awareness of bird flu among population
      • 5.1.1.3. Rising government initiatives to develop better therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Resistance of the virus to existing antiviral drugs and high costs associated with therapeutics development
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging investment for novel product development
      • 5.1.3.2. Ongoing clinical trials for bird flu treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory and approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bird Flu Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Antivirals
  • 6.3. Combination Treatment
  • 6.4. Prophylactic Antibiotics
  • 6.5. Ribavirin

7. Bird Flu Treatment Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospital
  • 7.4. Institutional Health Centers

8. Americas Bird Flu Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bird Flu Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bird Flu Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech, Inc.
  • 2. BioCryst Pharmaceuticals, Inc.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Ceva Sante Animale
  • 5. Cipla Limited
  • 6. CSL Limited
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. FATRO S.p.A.
  • 9. Gilead Sciences, Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Hester Biosciences Limited
  • 12. Johnson & Johnson Services, Inc.
  • 13. Macleods Pharmaceuticals Ltd
  • 14. Merck KGaA
  • 15. Moderna, Inc.
  • 16. Novartis AG
  • 17. PetSmart LLC
  • 18. Pfizer Inc.
  • 19. Sanofi S.A.
  • 20. Serum Institute of India Pvt. Ltd.
  • 21. Sinovac Biotech Ltd.
  • 22. Takeda Pharmaceutical Company Limited
  • 23. Tianjin Ringpu Biotechnology Co. Ltd.
  • 24. Yebio Bioengineering Co. Ltd.
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. BIRD FLU TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BIRD FLU TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIRD FLU TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COMBINATION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PROPHYLACTIC ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY RIBAVIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY INSTITUTIONAL HEALTH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023